Liisa Kaartinen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Liisa Kaartinen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Heidi Härtel
University of Helsinki, Faculty of Veterinary Medicine, Department of Clinical Sciences, FIN-04920 Saarentaus, Finland
1 shared publicationM. Moilanen
National Agency for Medicines, PO Box 55, FIN‐00301 Helsinki, Finland
1 shared publicationMarina Gips
Kimron Veterinary Institute, National Residue Control Laboratory, PO Box 12, 50250 Beit Dagan, Israel
1 shared publicationS. Pyörälä
National Agency for Medicines, PO Box 55, FIN‐00301 Helsinki, Finland
1 shared publicationS. Räisänen
National Agency for Medicines, PO Box 55, FIN‐00301 Helsinki, Finland
1 shared publicationSatu Pyörälä
University of Helsinki, Faculty of Veterinary Medicine, Department of Clinical Sciences, FIN-04920 Saarentaus, Finland
1 shared publication
Latest Publications
- Open Access
- 1 September 2000
- Published by EDP Sciences in Veterinary Research
- Vol. 31 (5) , 517-526
Pharmacokinetics of sulphadoxine and trimethoprim and tissue irritation caused by two sulphadoxine-trimethoprim containing products after subcutaneous administration in pre-ruminant calves
Veterinary Research, a journal on Animal Infection
- 1 September 2000
- Published by EDP Sciences in Veterinary Research
- Vol. 31 (5) , 517-526
Open AccessPharmacokinetics of sulphadoxine and trimethoprim and tissue irritation caused by two sulphadoxine-trimethoprim containing products after subcutaneous administration in pre-ruminant calves
Veterinary Research, a journal on Animal Infection
- 1 December 1997
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 20 (6) , 479-482
Pharmacokinetics of enrofloxacin in newborn and one‐week‐old calves
The pharmacokinetic behaviour of enrofloxacin was compared in four one‐day‐old and four one‐week‐old calves in order to find out if there were any age‐related differences. Mean volume of distribution (Vd(ss)) and clearance (Cl) were significantly smaller in newborn calves: Vd(ss) was 1.8 and 2.3 L/kg, while clearance was 0.19 and 0.39 L/kg.h in newborn and one‐week‐old calves, respectively. Mean elimination half‐life (t1/2β) did not differ significantly in newborn and in one‐week‐old calves: mean t1/2β was 6.6 h and 4.9 h, respectively. Enrofloxacin was metabolized to ciprofloxacin both by newborn and one‐week‐old calves, but the maximum concentration (Cmax) of ciprofloxacin was lower and the time when maximum concentration was reached (tmax) later in newborn calves. We conclude that the dosage of enrofloxacin should be adjusted according to age when administered to very young calves.
- 1 December 1997
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 20 (6) , 479-482
Pharmacokinetics of enrofloxacin in newborn and one‐week‐old calves
The pharmacokinetic behaviour of enrofloxacin was compared in four one‐day‐old and four one‐week‐old calves in order to find out if there were any age‐related differences. Mean volume of distribution (Vd(ss)) and clearance (Cl) were significantly smaller in newborn calves: Vd(ss) was 1.8 and 2.3 L/kg, while clearance was 0.19 and 0.39 L/kg.h in newborn and one‐week‐old calves, respectively. Mean elimination half‐life (t1/2β) did not differ significantly in newborn and in one‐week‐old calves: mean t1/2β was 6.6 h and 4.9 h, respectively. Enrofloxacin was metabolized to ciprofloxacin both by newborn and one‐week‐old calves, but the maximum concentration (Cmax) of ciprofloxacin was lower and the time when maximum concentration was reached (tmax) later in newborn calves. We conclude that the dosage of enrofloxacin should be adjusted according to age when administered to very young calves.